Simple Science

Cutting edge science explained simply

# Biology # Genetics

Breaking New Ground in Heart Gene Editing

CASAAV-HDR combines CRISPR and viral techniques for heart disease research.

Yanjiang Zheng, Joshua Mayourian, Justin S. King, Yifei Li, Vassilios J. Bezzerides, William T. Pu, Nathan J. VanDusen

― 5 min read


Advancing Heart Gene Advancing Heart Gene Editing through precise DNA edits. CASAAV-HDR transforms cardiac research
Table of Contents

CRISPR-Cas9 is a tool that allows scientists to make precise changes to DNA. Think of it as a pair of molecular scissors that can cut DNA at specific locations to either fix or change genes. This system comes from the immune system of bacteria, which use it to fend off viruses.

The Basics of Gene Editing

Gene editing with CRISPR-Cas9 has taken the scientific world by storm. It's become popular because it is relatively easy to program and offers better efficiency when targeting specific sections of DNA compared to older methods. These previous methods, like ZFNs and TALENs, were more complicated and less effective.

By creating targeted cuts in DNA, scientists can influence how genes behave. The cell will attempt to fix the cuts, and during this repair process, changes can occur, leading to the desired outcome. This is especially useful when dealing with genetic diseases.

What Happens Next?

When CRISPR-Cas9 cuts DNA, the cell has a couple of ways to mend the break. Usually, it employs a method called non-homologous end joining (NHEJ), which is fast but can lead to random insertions and deletions in the DNA sequence. While this can disrupt genes, it sometimes leads to the desired result.

Alternatively, if scientists provide a template for repair called a donor template, the cell can use a more precise method called homology-directed repair (HDR). This way, researchers can make specific changes to the DNA, such as fixing a mutation or adding new genetic material.

The Birth of CASAAV-HDR

Enter CASAAV-HDR, a new approach combining CRISPR-Cas9 with a type of virus called adeno-associated virus (AAV). This platform makes it easier to deliver CRISPR components and donor templates to cells, specifically targeting those that are important for heart health, called cardiomyocytes.

CASAAV-HDR allows scientists to create precise edits in heart cells, with up to 45% success in making changes at the neonatal stage. Imagine being able to flip a switch in the heart cells to see how they react-CASAAV-HDR does just that!

Modeling Heart Diseases

Let’s say scientists want to study a heart problem. They can use CASAAV-HDR to create specific mutations in genes linked to diseases like Dilated Cardiomyopathy. By inserting a piece of glowing protein (called mScarlet) into a gene, researchers can watch how the mutated proteins behave inside the heart cells.

For instance, they could create mutations in the TTN gene, which makes a protein called titin. This protein plays a vital role in heart contraction. Researchers found that these mutations produce truncated proteins that don't function correctly because they're like a half-finished engine. By watching how these proteins are placed in cells (thanks to the mScarlet tagging), scientists gain insights into how mutations cause diseases.

The Importance of Phospholamban

Another important area of study involves a protein called phospholamban (PLN). PLN regulates calcium levels in heart cells, which is crucial for heart contractions. A specific mutation called R14Del in the PLN gene can disrupt this regulation, leading to heart issues.

Using CASAAV-HDR, scientists can edit the PLN gene to study how the mutation affects protein behavior. They found that even though the protein's location in the cells remains largely unchanged, the function of PLN is impaired, leading to problems with how calcium moves in and out of heart cells.

The Power of Massively Parallel Reporter Assays

In the world of gene regulation, scientists are interested in understanding what makes some genes more active than others. To tackle this, they developed massively parallel reporter assays (MPRAs). These assays help examine many genes simultaneously to understand how different regions of DNA, known as enhancers, regulate gene activity.

Using CASAAV-HDR, researchers can precisely insert these enhancers into specific locations in the genome. For instance, they targeted the Tnni1 gene, which is important for heart function. By integrating enhancers into this gene, they could study how much more active it became in the heart cells.

The results were promising: they found that certain enhancers increased gene activity effectively, paving the way for deeper exploration into gene regulation.

Limitations and Future Prospects

While CASAAV-HDR shows tremendous promise, it's not without limitations. The efficiency of making edits can vary depending on where the DNA is being targeted. Sometimes, the editing doesn’t work out as scientists hope, leading to mixed results within the same tissue.

However, CASAAV-HDR allows researchers to label successfully edited cells, making them easier to study. Even with its constraints, CASAAV-HDR provides fantastic opportunities for scientists to understand genetic diseases better and to explore ways to treat them.

Conclusion: A Bright Future Ahead

CASAAV-HDR represents a significant leap forward in gene editing technology. It has opened up new avenues in the field of cardiology, enabling researchers to model diseases and study gene functions more effectively. With this tool, the scientific community is now better equipped to tackle genetic diseases and potentially develop new therapies.

As scientists continue to explore other possible applications of CASAAV-HDR, such as gene therapy and cloning, we can expect exciting advancements in how we understand and treat heart diseases. All of this work suggests that the future of genetics is bright, and who knows? Maybe one day, we will be able to fix broken hearts in more than just the emotional sense!

Original Source

Title: Cardiac Applications of CRISPR/AAV-Mediated Precise Genome Editing

Abstract: The ability to efficiently make precise genome edits in somatic tissues will have profound implications for gene therapy and basic science. CRISPR/Cas9 mediated homology-directed repair (HDR) is one approach that is commonly used to achieve precise and efficient editing in cultured cells. Previously, we developed a platform capable of delivering CRISPR/Cas9 gRNAs and donor templates via adeno-associated virus to induce HDR (CASAAV-HDR). We demonstrated that CASAAV-HDR is capable of creating precise genome edits in vivo within mouse cardiomyocytes at the neonatal and adult stages. Here, we report several applications of CASAAV-HDR in cardiomyocytes. First, we show the utility of CASAAV-HDR for disease modeling applications by using CASAAV-HDR to create and precisely tag two pathological variants of the titin gene observed in cardiomyopathy patients. We used this approach to monitor the cellular localization of the variants, resulting in mechanistic insights into their pathological functions. Next, we utilized CASAAV-HDR to create another mutation associated with human cardiomyopathy, arginine 14 deletion (R14Del) within the N-terminus of Phospholamban (PLN). We assessed the localization of PLN-R14Del and quantified cardiomyocyte phenotypes associated with cardiomyopathy, including cell morphology, activation of PLN via phosphorylation, and calcium handling. After demonstrating CASAAV-HDR utility for disease modeling we next tested its utility for functional genomics, by targeted genomic insertion of a library of enhancers for a massively parallel reporter assay (MPRA). We show that MPRAs with genomically integrated enhancers are feasible, and can yield superior assay sensitivity compared to tests of the same enhancers in an AAV/episomal context. Collectively, our study showcases multiple applications for in vivo precise editing of cardiomyocyte genomes via CASAAV-HDR.

Authors: Yanjiang Zheng, Joshua Mayourian, Justin S. King, Yifei Li, Vassilios J. Bezzerides, William T. Pu, Nathan J. VanDusen

Last Update: 2024-12-04 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.03.626493

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.03.626493.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles